BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/24/2022 9:00:24 AM | Browse: 235 | Download: 546
 |
Received |
|
2021-08-08 05:06 |
|
Peer-Review Started |
|
2021-08-08 05:09 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-11-06 19:45 |
|
Revised |
|
2021-11-15 03:12 |
|
Second Decision |
|
2022-05-05 03:14 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-05-07 00:11 |
|
Articles in Press |
|
2022-05-07 00:11 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-04-29 02:44 |
|
Typeset the Manuscript |
|
2022-06-16 11:52 |
|
Publish the Manuscript Online |
|
2022-06-24 09:00 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Arteriovenous thrombotic events in a patient with advanced lung cancer following bevacizumab plus chemotherapy: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ying Kong, Xiao-Cheng Xu and Liang Hong |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Liang Hong, MD, PhD, Associate Chief Physician, Department of Oncology, The First People’s Hospital of Xiaoshan District, Xiaoshan Affiliated Hospital of Wenzhou Medical University, No. 199 Shixin South Road, Xiaoshan District, Hangzhou 311200, Zhejiang Province, China. kongying1504@163.com |
| Key Words |
Cerebral infarction; Pulmonary embolism; Bevacizumab; Chemotherapy; Non-small cell lung cancer; Case report |
| Core Tip |
This report describes a middle-aged man with postoperative recurrence of non-small cell lung cancer who developed cerebral infarction and pulmonary embolism 6 mo after treatment with bevacizumab, which was given in combination with chemotherapy. Concurrent arteriovenous thrombosis is rarely reported in the literature. Bevacizumab in conjunction with chemotherapy may increase the risk of arteriovenous thromboembolism. As a result, patients who undergo treatment with angiogenesis inhibitors should be carefully selected, and close monitoring and timely interventions (such as low-molecular-weight heparin prophylactic anticoagulant therapy) are necessary in order to reduce the risk of arterial thromboembolism and venous thromboembolism. |
| Publish Date |
2022-06-24 09:00 |
| Citation |
Kong Y, Xu XC, Hong L. Arteriovenous thrombotic events in a patient with advanced lung cancer following bevacizumab plus chemotherapy: A case report. World J Clin Cases 2022; 10(19): 6507-6513 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i19/6507.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i19.6507 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
